Cervical cancer is the leading cause of cancer death among women worldwide. Although
regular screening dramatically reduces the incidence and death from cervical cancer …

With the introduction of cervical screening programs, the incidence and mortality of cervical
cancer has been drastically reduced. Techniques such as the traditional Papanicolaou test …

Cervical cancer is responsible for more gynecologic-related deaths worldwide than any
other malady, making it the most important preventable disease in women's health today …

Few new developments in gynaecological oncology have the potential to save as many lives
as the human papillomavirus (HPV) vaccines Cervarix™ and Gardasil®. These vaccines …

Estimates of the direct medical costs attributable to human papillomavirus (HPV) can help to
quantify the economic burden of HPV and to illustrate the potential benefits of HPV …

News cost of $330 and a booster at $100) would save $54 million in treatment costs over 26
years. But it would cost $373.6 million.“That's just saying we're avoiding the cost of …

Background: Despite screening, cervical cancer (CC) remains a serious health care
problem. Because human papillomavirus (HPV) is the necessary cause of CC, the …

The annual direct medical cost attributable to human papillomavirus (HPV) in the United
States over the period 2004–2007 was estimated at $9.36 billion in 2012 (updated to 2020 …

Two common concerns that are raised with regard to human papillomavirus (HPV)
vaccination are that:(1) because the vaccine clinical trial endpoints were highgrade cervical …

Vaccines to prevent infection with the human papillomavirus (HPV) have recently been
approved for use in preventing cervical precancer and cancer. This paper reviews the HPV …